busulfan   Click here for help

GtoPdb Ligand ID: 7136

Synonyms: Busulfex IV® | Myleran®
Approved drug
busulfan is an approved drug (FDA (1954), EMA (2003))
Compound class: Synthetic organic
Comment: Busulfan is a DNA alkylating agent. It has an immunosuppressive effect on bone marrow, especially inhibiting growth of granulocytes.
Click here for help
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: busulfan

2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 0
Rotatable bonds 7
Topological polar surface area 103.5
Molecular weight 246.02
XLogP -1.23
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES CS(=O)(=O)OCCCCOS(=O)(=O)C
Isomeric SMILES CS(=O)(=O)OCCCCOS(=O)(=O)C
InChI InChI=1S/C6H14O6S2/c1-13(7,8)11-5-3-4-6-12-14(2,9)10/h3-6H2,1-2H3
No information available.
Summary of Clinical Use Click here for help
Busulfan is used as palliative care in patients with chronic myeloid leukemia (CML). It is also used to pre-condition (ie immunosuppress) patients prior to undergoing bone marrow transplant (autologous or allogenic hematopoietic stem cell transplantation) as treatment for leukemias.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
As a DNA alkylating (cross-linking) agent, busulfan treatment irreversibly interferes with DNA replication, RNA transcription and general disruption of nucleic acid function. This action causes cell death. Due to the complex and varied nature of nucleic acids we do not include DNA or RNA as targets on this database.
External links Click here for help